Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
暂无分享,去创建一个
Josep Roca | Xavier Freixa | Xavier Basagaña | Antoni Ferrer | Jaume Ferrer | Marta Benet | Joaquim Gea | Judith Garcia-Aymerich | X. Basagaña | J. Barberà | F. Gómez | J. Roca | A. Agustí | M. Benet | J. Garcia-Aymerich | J. Antó | X. Freixa | A. Ferrer | J. Gea | E. Monso | E. Farrero | J. Galdiz | Jaume Sauleda | J. Sauleda | Eva Farrero | Joan A Barberà | Josep M Antó | Federico P Gómez | Eduard Monsó | Carles Paré | C. Paré | Àngel Gayete | Juan B Gáldiz | Àlvar Agustí | Á. Gayete | J. Ferrer | Jaume Ferrer
[1] S. Haque. Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed. , 2011 .
[2] A. Sood. Pulmonary Physiology and Pathophysiology in Obesity Obesity , adipokines , and lung disease , 2010 .
[3] D. Caillaud,et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.
[4] D. Jarvis,et al. Early life origins of chronic obstructive pulmonary disease , 2009, Thorax.
[5] F. Gómez,et al. Characteristics of patients admitted for the first time for COPD exacerbation. , 2009, Respiratory medicine.
[6] Ulrike Held,et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.
[7] C. Goldsmith,et al. How to use an article about prognosis. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.
[8] Dave Singh,et al. COPD phenotype description using principal components analysis , 2009, Respiratory research.
[9] M. Weatherall,et al. Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.
[10] J. Barberà,et al. Phenotypic Heterogeneity of Chronic Obstructive Pulmonary Disease , 2009 .
[11] A. Ferrer,et al. La heterogeneidad fenotpica de la EPOC , 2009 .
[12] Alexander Rokitansky,et al. Thorax , 2009, Pediatric Surgery Digest.
[13] Judith Garcia-Aymerich,et al. Phenotypic Characterization and Course of Chronic Obstructive Pulmonary Disease in the PAC-COPD Study: Design and Methods , 2009 .
[14] J. Garcia-Aymerich,et al. Caracterización fenotípica y evolución de la EPOC en el estudio PAC-COPD: diseño y metodología , 2009 .
[15] J. Barberà,et al. [Phenotypic heterogeneity of chronic obstructive pulmonary disease]. , 2009, Archivos de bronconeumologia.
[16] J. Reilly. COPD and declining FEV1--time to divide and conquer? , 2008, The New England journal of medicine.
[17] K. Rabe,et al. From COPD to chronic systemic inflammatory syndrome? , 2007, The Lancet.
[18] Antonio Anzueto,et al. Patient's perception of exacerbations of COPD--the PERCEIVE study. , 2006, Respiratory medicine.
[19] Ricardo Fraiman,et al. Selection of Variables for Cluster Analysis and Classification Rules , 2006, math/0610757.
[20] T. Lancet. A plea to abandon asthma as a disease concept , 2006, The Lancet.
[21] S. Wenzel. Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.
[22] Douglas Steinley,et al. K-means clustering: a half-century synthesis. , 2006, The British journal of mathematical and statistical psychology.
[23] P. Calverley,et al. Is Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) a Risk Factor for Cardiovascular Events? , 2006, COPD.
[24] C. Lenfant,et al. Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .
[25] I. Pavord,et al. Multi‐dimensional phenotyping: towards a new taxonomy for airway disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] Jonathan L Haines,et al. Genetics, statistics and human disease: analytical retooling for complexity. , 2004, Trends in genetics : TIG.
[27] Jan Stolk,et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[28] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[29] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[30] S. Kira. [Respiratory insufficiency]. , 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.
[31] D. Postma,et al. Chronic obstructive pulmonary disease. , 2002, Clinical evidence.
[32] M. Cadopi,et al. Factor Analysis of Quality of Life, Dyspnea, and Physiologic Variables in Patients with Chronic Obstructive Pulmonary Disease Before and After Rehabilitation , 2001, American journal of physical medicine & rehabilitation.
[33] Konsulov Ss,et al. Selective neck dissection in treatment of node-positive neck cases. , 2001 .
[34] S. Kostianev,et al. A factor analysis of dyspnea indexes and lung function parameters in patients with chronic obstructive pulmonary disease. , 2001, Folia medica.
[35] H. Boshuizen,et al. Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.
[36] M. Ferrer,et al. Chronic Obstructive Pulmonary Disease Stage and Health-Related Quality of Life , 1997, Annals of Internal Medicine.
[37] J. Alonso,et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. , 1997, Annals of internal medicine.
[38] P Tugwell,et al. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. , 1994, JAMA.
[39] Gordon H. Guyatt,et al. Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis , 1994 .
[40] H. Magnussen,et al. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. , 1994, The European respiratory journal.
[41] G. Guyatt,et al. Users' guides to the medical literature. , 1993, JAMA.
[42] A. Harver,et al. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.
[43] R. Kaplan,et al. Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease. , 1991, Journal of clinical epidemiology.
[44] J. Bloom,et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. , 1987, The New England journal of medicine.
[45] D. Rubin. INFERENCE AND MISSING DATA , 1975 .
[46] R. Eberhart,et al. Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation. , 1972 .
[47] A. Leatham,et al. External electric stimulator for treatment of ventricular standstill. , 1956, Lancet.